Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Immunophilin-ligand complexes as probes of intracellular signaling pathways.

Schreiber SL, Liu J, Albers MW, Karmacharya R, Koh E, Martin PK, Rosen MK, Standaert RF, Wandless TJ.

Transplant Proc. 1991 Dec;23(6):2839-44. Review. No abstract available.

PMID:
1721293
2.

Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.

Bierer BE.

Proc Assoc Am Physicians. 1995 Apr;107(1):28-40. Review. No abstract available.

PMID:
8630742
3.

Modes of action of FK506, cyclosporin A, and rapamycin.

Morris R.

Transplant Proc. 1994 Dec;26(6):3272-5. Review. No abstract available.

PMID:
7527964
4.

Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.

Bierer BE.

Chem Immunol. 1994;59:128-55. No abstract available.

PMID:
7524531
5.

Categorizing receptor-signaling pathways with FK 506 and rapamycin.

Hultsch T, Hohman RJ.

Transplant Proc. 1991 Dec;23(6):2961-3. Review. No abstract available.

PMID:
1721328
6.

FK 506 and rapamycin: molecular probes of T-lymphocyte activation.

Bierer BE, Jin YJ, Fruman DA, Calvo V, Burakoff SJ.

Transplant Proc. 1991 Dec;23(6):2850-5. Review. No abstract available.

PMID:
1721296
7.

Molecular mechanisms of immunosuppressive agents.

Borel JF, Baumann G.

Bull Mem Acad R Med Belg. 1994;149(1-2):97-101; discussion 101-3.

PMID:
7531051
8.
9.

Immunophilins: beyond immunosuppression.

Hamilton GS, Steiner JP.

J Med Chem. 1998 Dec 17;41(26):5119-43. Review. No abstract available.

PMID:
9857082
10.

The actions of cyclosporin A and FK506 on T-lymphocyte activation.

Mattila PS.

Biochem Soc Trans. 1996 Feb;24(1):45-9. Review. No abstract available.

PMID:
8674715
11.

Immunophilin receptors for immunosuppressive drugs.

Soldin SJ, Murthy JN, Donnelly JG, Chen Y, Goodyear N.

Ther Drug Monit. 1993 Dec;15(6):468-71. Review.

PMID:
7510077
12.

Lessons from molecular matchmakers.

Teague S.

Nat Struct Biol. 1995 May;2(5):360-1. No abstract available.

PMID:
7545076
13.

Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.

Hultsch T, Albers MW, Schreiber SL, Hohman RJ.

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6229-33.

14.

Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin.

Denesyuk AI, Denessiouk KA, Zav'yalov VP, Lundell J, Korpela T.

Comput Chem. 1998 Jun 20;22(4):339-44.

PMID:
9680690
15.

Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?

Schreier MH, Baumann G, Zenke G.

Transplant Proc. 1993 Feb;25(1 Pt 1):502-7. Review. No abstract available.

PMID:
7679818
16.

Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.

Kunz J, Hall MN.

Trends Biochem Sci. 1993 Sep;18(9):334-8. Review.

PMID:
7694398
17.

The chemistry of signal transduction.

Clardy J.

Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):56-61. Review.

18.

Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner.

Su MS, Semerjian A.

Transplant Proc. 1991 Dec;23(6):2912-5. No abstract available.

PMID:
1721310
19.

Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.

Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J.

J Mol Biol. 1993 Jan 5;229(1):105-24.

PMID:
7678431
20.

Probing immunosuppressant action with a nonnatural immunophilin ligand.

Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL.

Science. 1990 Oct 26;250(4980):556-9.

PMID:
1700475

Supplemental Content

Support Center